Changes in resting energy expenditure (REE) as a function of tumor response to sunitinib in a cachexic patient with a metastatic endocrine tumor of the pancreas.
Zoheir
Yasmina
Y
Leroux
Catherine
C
Picot
Denis
D
Boucher
Eveline
E
Audrain
Odile
O
Raoul
Jean-Luc
JL
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002100:Cachexia / Q000209:etiology / Q000378:metabolism*; D002153:Calorimetry, Indirect; D004435:Eating; D004734:Energy Metabolism / Q000187:drug effects*; D006498:Hepatectomy / Q000379:methods; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000556:secondary / Q000601:surgery; D008297:Male; D008875:Middle Aged; D010180:Pancreatectomy; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology*; D011758:Pyrroles / Q000627:therapeutic use*; D012146:Rest; D013156:Splenectomy; D000077210:Sunitinib; D016896:Treatment Outcome; D015431:Weight Loss
D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib